Viewing StudyNCT00224133



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00224133
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2005-09-14

Brief Title: The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Sponsor: Watson Pharmaceuticals
Organization: Watson Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Benign Prostatic Hyperplasia
Keywords:
Name View
benign prostatic hyperplasia alpha blocker View